[1]
“Design, characterization and evaluation of a novel dosage form of rebamipide as transdermal patches in rodent model of Parkinson’s disease”, Prospect. Pharm. Sci., vol. 24, no. 2, pp. 113–130, Feb. 2026, doi: 10.56782/pps.650.